Clincosm LogoSign in Get a demo

Ovarian Neoplasms

Showing 26 - 50 of 220
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Spectroscopy in Ovarian Cancer

Recruiting
  • Ovarian Cancer
  • +3 more
    • Bristol, United Kingdom
      University Hospitals Bristol and Weston NHS Trust
    Oct 4, 2022

    Ovarian Cancer, Oligometastatic Disease, Recurrent Ovary Cancer Trial (Stereotactic body radiotherapy)

    Recruiting
    • Ovarian Neoplasms
    • +2 more
    • Stereotactic body radiotherapy
    • Campobasso, CB, Italy
    • +7 more
    Sep 23, 2022

    Engrailed (EN)-2 in Epithelial Ovarian Neoplasms

    Completed
    • Ovarian Neoplasms
    • Immunohistochemical staining of normal and neoplastic ovarian tissues by anti human Engrailed-2 antibody.
    • Sohag, Egypt
      Sohag faculty of medicine
    Sep 25, 2022

    Ovarian Cancer, Ovarian Tumors, Ovarian Carcinoma Trial in United States (ELU001)

    Recruiting
    • Ovarian Cancer
    • +68 more
    • Phoenix, Arizona
    • +8 more
    Aug 18, 2022

    Peritoneal Carcinomatosis, Peritoneal Tumors, Ovarian Cancer Trial run by the National Cancer Institute (NCI) (Paclitaxel,

    Not yet recruiting
    • Peritoneal Carcinomatosis
    • +7 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Aug 17, 2022

    NSCLC, Squamous Cell Carcinoma of the Head and Neck, Esophageal Squamous Cell Carcinoma Trial in San Antonio, West Valley City,

    Recruiting
    • Carcinoma, Non-Small-Cell Lung
    • +4 more
    • San Antonio, Texas
    • +2 more
    Aug 15, 2022

    Ovarian Tumors, Peritoneal Tumors, Fallopian Tube Tumors Trial in United States (SGN-B7H4V)

    Recruiting
    • Ovarian Neoplasms
    • +9 more
    • Aurora, Colorado
    • +6 more
    Aug 15, 2022

    Carcinoma, Non-Small Cell Lung, HER2 Negative Breast Tumors, Ovarian Tumors Trial in Worldwide (SGN-STNV)

    Recruiting
    • Carcinoma, Non-Small Cell Lung
    • +11 more
    • Los Angeles, California
    • +16 more
    Aug 15, 2022

    Ovarian Cancer, Ovarian Tumors, Ovarian Carcinoma Trial in Santa Monica, Pittsburgh, Houston (TTI-622, Pegylated Liposomal

    Recruiting
    • Ovarian Cancer
    • +5 more
    • TTI-622
    • Pegylated Liposomal Doxorubicin
    • Santa Monica, California
    • +4 more
    Jul 26, 2022

    Tumors, Colorectal Tumors, Melanoma Trial in United States (Alectinib)

    Terminated
    • Neoplasms
    • +27 more
    • Culver City, California
    • +28 more
    Jul 25, 2022

    NSCLC, Colorectal Neoplams, Endometrial Tumors Trial in Worldwide (LY3537982, Abemaciclib, Erlotinib)

    Recruiting
    • Carcinoma, Non-Small-Cell Lung
    • +4 more
    • Los Angeles, California
    • +21 more
    Jul 22, 2022

    Ovarian Tumors, Breast Tumors Trial in Worldwide (Niraparib)

    Active, not recruiting
    • Ovarian Neoplasms
    • Breast Neoplasms
    • Tucson, Arizona
    • +22 more
    Jul 20, 2022

    Ovarian Tumors Trial in Worldwide (Tilvestamab)

    Recruiting
    • Ovarian Neoplasms
    • Tilvestamab
    • Seoul, Korea, Republic of
    • +8 more
    Jul 19, 2022

    Genital Diseases, Female, Ovarian Diseases, Ovarian Tumors Trial in Worldwide (biological, drug, other)

    Completed
    • Genital Diseases, Female
    • +4 more
    • Bevacizumab
    • +3 more
    • Aalborg, Denmark
    • +130 more
    Jul 19, 2022

    Mesothelioma, Mesotheliomas Pleural, Mesothelioma, Malignant Trial in Bethesda, Nashville (TC-510, Fludarabine,

    Recruiting
    • Mesothelioma
    • +14 more
    • TC-510
    • +2 more
    • Nashville, Tennessee
      Sarah Cannon Research Institute
    Jul 14, 2022

    Germ Cell Tumors, Testicular Tumors, Non Seminomatous Germ Cell Tumors Trial in Indianapolis, Philadelphia (Pembrolizumab)

    Terminated
    Has Results
    • Germ Cell Neoplasms
    • +6 more
    • Indianapolis, Indiana
    • +1 more
    Jul 7, 2022

    First-line Olaparib Combined With Bevacizumab Maintenance

    Not yet recruiting
    • Ovarian Neoplasms
    • olaparib plus bevacizumab maintenance therapy
    • (no location specified)
    Jun 29, 2022

    Estimate Risk of Cancer in Gynecology Patients Presenting

    Completed
    • Ovarian Neoplasms
    • Pelvic imaging
    • +2 more
    • Rochester, New York
      University of Rochester Medical Center Wilmot Cancer Institute
    Jun 27, 2022

    Lynch Syndrome, Endometrial Tumors, Ovarian Tumors Trial in Toronto (Questionnaire, Educational Material)

    Active, not recruiting
    • Lynch Syndrome
    • +3 more
    • Questionnaire, Educational Material
    • Toronto, Ontario, Canada
      University Health Network - Princess Margaret Hospital
    May 16, 2022

    Different Follow-up Modalities on Overall Survival in Ovarian

    Recruiting
    • Patient Reported Outcome Measures
    • Ovarian Neoplasms
    • Mobile app ovarian cancer followup (ePRO)
    • Schlieren, Zürich, Switzerland
    • +3 more
    Apr 29, 2022

    Ovarian Tumors, Ovarian Epithelial Cancer Trial in Czechia, Poland (DCVAC/OvCa with Standard of Care, DCVAC/OvCa sequentially

    Completed
    • Ovarian Neoplasms
    • Ovarian Epithelial Cancer
    • DCVAC/OvCa with Standard of Care
    • +2 more
    • Brno, Czechia
    • +12 more
    May 3, 2022

    Developing a Test for the Detection of Ovarian Cancer

    Recruiting
    • Ovarian Neoplasms
    • +14 more
    • Uterine lavage, or a wash of the womb
    • +2 more
    • Little Rock, Arkansas
    • +5 more
    Apr 29, 2022

    Blood Collection From People With Ovarian Cancer

    Completed
    • Ovarian Cancer
    • +2 more
      • Bethesda, Maryland
        National Institutes of Health Clinical Center, 9000 Rockville Pi
      Apr 7, 2022

      Ovarian Tumors, Peritoneal Tumors, Fallopian Tube Tumors Trial in India (Bevacizumab)

      Recruiting
      • Ovarian Neoplasms
      • +2 more
      • Vijayawada, Andhra Pradesh, India
      • +24 more
      Apr 1, 2022

      Ovarian Tumors Trial (Pembrolizumab)

      Completed
      Has Results
      • Ovarian Neoplasms
      • Pembrolizumab
      • (no location specified)
      Feb 23, 2022